Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Suppan, C.
Post San Antonio update-my top three abstracts!
MEMO-MAG EUR MED ONC. 2021; Doi: 10.1007/s12254-021-00718-0
Web of Science FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Suppan Christoph

Dimensions Citations:
Plum Analytics:

Scite (citation analytics):

Recent findings support the role of alpelisib in advanced HR-positive breast cancer harboring a PIK3CA mutation. A retrospective biomarker analysis on the intrinsic subtypes of HR-positive breast cancer reveals a subgroup that will not benefit under the addition of a CDK 4/6 inhibitor treatment. The detection of circulating tumor cells before start and during tumor treatment is associated with worse outcome in metastatic breast cancer patients.

Find related publications in this database (Keywords)
Metastatic breast cancer
6 inhibitor
Endocrine resistance
PIK3CA mutations
Circulating tumor cells
© Med Uni Graz Impressum